Search Results

A Study of Setanaxib Co-Administered With Pembrolizumab in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of Head and Neck (SCCHN)

• Source: A Phase 2, Randomised, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Setanaxib, When Administered With Pembrolizumab, in Patients With Recurrent or

Record details

NT-I7 for the Treatment of Recurrent Squamous Cell Carcinoma of Head and Neck Undergoing Surgery

• Authors : NeoImmuneTech; Hyunseok Kang, MD, Principal Investigator

• Source: A Window of Opportunity Trial of NT-I7 in Patients With Locally Recurrent Squamous Cell Carcinoma of

Record details

1922GCCC: Pembro and Bavituximab for Squamous Cell Carcinoma of Head and Neck

• Source: 1922GCCC: PHASE 2 STUDY OF PEMBROLIZUMAB AND BAVITUXIMAB FOR PROGRESSIVE RECURRENT/METASTATIC SQUAMOUS CELL

Record details

Indian clinical practice consensus guidelines for the management of recurrent, persistent, or metastatic squamous cell carcinoma of head-and-neck - Update 2023

• Authors : Vanita Noronha; K Govind Babu; HS Darling

Subjects: 03 medical and health sciences; recurrent; 0302 clinical medicine

• Source: Cancer Research, Statistics, and Treatment, Vol 7, Iss Suppl 2, Pp S69-S73 (2024)

Record details

Valproic Acid Plus Cisplatin and Cetuximab in Recurrent and/or Metastatic Squamous Cell Carcinoma of Head and Neck (V-CHANCE)

• Source: Preclinical and Clinical Study of Valproic Acid Plus Cisplatin and Cetuximab in Recurrent and/or Metastatic Squamous Cell

Record details

Concurrent chemoradiation with low-dose and long-duration weekly infusion of gemcitabine in unresectable squamous cell carcinoma of head and neck (SCCHN).

• Authors : Ahmad F; Department of Radiotherapy, Jawaharlal Nehru Medical College & Hospital, Aligarh Muslim University, Aligarh, Uttar Pradesh, India.; Akram M

Subjects: Gemcitabine* ; Deoxycytidine*/Deoxycytidine*/Deoxycytidine*/analogs & derivatives ; Deoxycytidine*/Deoxycytidine*/Deoxycytidine*/administration & dosage

• Source: Journal of cancer research and therapeutics [J Cancer Res Ther] 2024 Apr 01; Vol. 20 (3), pp. 827-831. Date of Electronic Publication: 2024 Jun 27.Publisher: Medknow Publications Country of Publication: India NLM ID: 101249598 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

A retrospective study of thyroid functional status in patients treated with radiation therapy over head and neck region for squamous cell carcinoma of head and neck

• Authors : Rina Barman; Sourav Sau; Pradip Kumar Maiti

Subjects: 03 medical and health sciences; 0302 clinical medicine

• Source: Indian Journal of Pathology and Oncology. 11:344-351

Record details

Definitive treatment in squamous cell carcinoma of head and neck: A retrospective analysis of chemoradiotherapy in a university hospital setting

• Authors : Hádila Silva Veras Sousa; Vivian Naomi Horita; Davi Magalhães Leite Novaes

Subjects: Head and neck squamous cell carcinoma; Definitive therapy; Outcome

• Source: Brazilian Journal of Otorhinolaryngology, Vol 91, Iss 4, Pp 101576- (2025)

Record details

PLATINUM-BASED CHEMORADIOTHERAPY AS DEFINITIVE TREATMENT IN ADVANCED SQUAMOUS CELL CARCINOMA OF HEAD AND NECK IN REAL-WORLD SETTING

• Authors : Hadila da Silva Veras Sousa; Vivian Naomi Horita; Matheus Yung Perin

Subjects: Definitive therapy; Head and neck squamous cell carcinoma; Outcome

• Source: Hematology, Transfusion and Cell Therapy, Vol 47, Iss , Pp 103782- (2025)

Record details

Neoadjuvant and Adjuvant Toripalimab and Cetuximab in Patients With Recurrent, Resectable Squamous Cell Carcinoma of Head and Neck: a Prospective, Single-arm,Phase II Study

• Source: Neoadjuvant and Adjuvant Toripalimab and Cetuximab in Patients With Recurrent, Resectable Squamous Cell

Record details